Form 4: Arcellx CMO Sells Shares for Tax Obligations

Arcellx's Chief Medical Officer, Christopher Heery, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax liabilities.

Summary

• Christopher Heery, Chief Medical Officer of Arcellx, Inc. (ACLX), reported transactions involving the company's common stock.
• On January 6, 2026, 13,064 shares of common stock were acquired through the vesting of restricted stock units (RSUs) at a price of $0.
• Following this acquisition, Heery beneficially owned 43,199 shares of common stock.
• On January 14, 2026, 5,882 shares of common stock were disposed of in a broker-assisted sale at a weighted average price of $68.5136 per share.
• This sale was conducted to satisfy tax withholding obligations related to the RSU vesting.
• After the sale, Heery beneficially owned 23,749 shares of common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving RSU vesting and a tax-related sale, which is generally considered neutral in terms of company sentiment.

Positives

• The vesting of restricted stock units indicates a component of executive compensation, aligning management's interests with shareholder value over time.

Negatives

• The sale of shares, while for tax purposes, reduces the insider's direct equity stake in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Management Comments

• The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The transaction is a routine insider disclosure and is unlikely to have a significant direct impact on shareholders, beyond the transparency of executive compensation and holdings.
• Employees: The vesting of RSUs is part of executive compensation, which can be a positive signal for employee retention and motivation within the company.

Key Dates

Keywords

Arcellx, ACLX, Form 4, Insider Transaction, RSU Vesting, Stock Sale, Chief Medical Officer, Tax Withholding